Large-scale testing (Phase 3)Study completedNCT02087722
What this trial is testing
Efficacy and Safety of KI1001 in the Treatment of ≥ 55 Years Old Insomnia Patients
Who this might be right for
Sleep Initiation and Maintenance Disorders
Kuhnil Pharmaceutical Co., Ltd. 80